Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ homolog subfamily B member 3 pseudogene (DNAJB3 pseudogene)
- Target
- DNAJB3 pseudogene
- Molecular classification
- Other (Pseudogene; processed pseudogene subtype)
01
Overview
DnaJ homolog subfamily B member 3 pseudogene (ENSG00000178836) is a non-functional genomic sequence related to the DNAJ/Hsp40 family of chaperones. Like other pseudogenes, it may play a role in gene network regulation via RNA mechanisms (such as acting as a competing endogenous RNA or generating small interfering RNAs). However, it does not produce a functional protein and is not considered a therapeutic target in clinical or pharmacological contexts. Most current research and gene databases do not link it to drug interactions, biomarkers, or direct disease mechanisms.
- Other names
- DnaJ (Hsp40) homolog, subfamily B, member 3 pseudogeneDNAJB3 pseudogeneENSG00000178836
02
Mechanism of action
Not applicable; pseudogenes are generally not targeted by drugs.
03
Biological functions
May contribute to gene regulatory networks through non-coding RNA mechanisms (as ceRNA, miRNA sponge, or producing antisense/small RNAs)No known direct protein-level function due to its pseudogene status
04
Disease associations
Pseudogenes have been implicated in cancer and other diseases through regulatory RNA effects, but there is no direct evidence for disease association of this specific pseudogene.For some pseudogenes, altered expression or regulatory activity may contribute to oncogenesis or other pathologies by modulating their parental gene’s function
05
Safety considerations
None reported; as a non-coding pseudogene, there are no known safety concerns or therapeutic challenges.
06
Interacting drugs
None reported. No drugs target the DNAJB3 pseudogene
07
Biomarkers
None reported specifically for patient selection or efficacy monitoring
Beyond the preview
Go deeper on DnaJ homolog subfamily B member 3 pseudogene (DNAJB3 pseudogene).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DnaJ homolog subfamily B member 3 pseudogene (DNAJB3 pseudogene).